Efficacy and safety of bivalirudin vs heparin plus glycoprotein IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized trials

被引：0
|
作者：
Jiang, Long [1 ]
Cheng, Xiaoshu [1 ]
Yang, Renqiang [1 ]
Hu, Lijuan [2 ]
Fan, Yingli [1 ]
Zhan, Rui [1 ]
机构：
[1] Nanchang Univ, Affiliated Hosp 2, Nanchang, Peoples R China
[2] Nanchang Univ, Affiliated Hosp 1, Nanchang, Peoples R China
来源：
CARDIOLOGY | 2013年 / 126卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：135 / 136
页数：2
相关论文
共 50 条
  • [41] Safety and Efficacy of Small Molecule Glycoprotein IIb/IIIa Inhibitors compared to Abciximab in Patients undergoing Primary PCI: A Meta-Analysis of Randomized Controlled Trials
    Tamhane, Umesh U.
    Meier, Pascal
    Grossman, Paul Michael
    Chetcuti, Stanley
    Gurm, Hitinder S.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A66 - A66
  • [42] Critical Appraisal of Bivalirudin versus Heparin for Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Trials
    Bavry, Anthony A.
    Elgendy, Islam Y.
    Mahmoud, Ahmed
    Jadhav, Manoj P.
    Huo, Tianyao
    [J]. PLOS ONE, 2015, 10 (05):
  • [43] Bivalirudin versus Heparin for Percutaneous Coronary Intervention: An Updated Meta-Analysis of Randomized Controlled Trials
    Lipinski, Michael J.
    Lhermusier, Thibault
    Escarcega, Ricardo O.
    Baker, Nevin C.
    Magalhaes, Marco A.
    Torguson, Rebecca
    Suddath, William O.
    Satler, Lowell F.
    Pichard, Augusto
    Waksman, Ron
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (11) : B137 - B137
  • [44] Bivalirudin versus heparin for percutaneous coronary intervention: an updated meta-analysis of randomized controlled trials
    Lipinski, Michael J.
    Lhermusier, Thibault
    Escarcega, Ricardo O.
    Baker, Nevin C.
    Magalhaes, Marco A.
    Torguson, Rebecca
    Suddath, William O.
    Satler, Lowell F.
    Pichard, Augusto D.
    Waksman, Ron
    [J]. CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2014, 15 (6-7) : 315 - 322
  • [45] Comparison of heparin plus IIb/IIIa inhibition versus bivalirudin with or without IIb/IIIa inhibition in patients with acute coronary syndromes undergoing percutaneous coronary intervention: The ACUITY trial
    Stone, Gregg W.
    White, Harvey D.
    Ohman, E. M.
    Bertrand, Michel E.
    Lincoff, A. M.
    McLaurin, Brent T.
    Cox, David A.
    Pocock, Stuart J.
    Ware, James H.
    Colombo, Antonio
    Mehran, Roxana
    Moses, Jeffrey W.
    [J]. CIRCULATION, 2006, 114 (18) : 551 - 551
  • [46] Intralesional versus intracoronary administration of glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention in patients with acute coronary syndromes A meta-analysis of randomized controlled trials
    Sun, Binjie
    Liu, Zhen
    Yin, Hongshan
    Wang, Tao
    Chen, Tao
    Yang, Sen
    Jiang, Zhian
    [J]. MEDICINE, 2017, 96 (40)
  • [47] Optimal Antithrombotic therapy in patients on hemodialysis requiring percutaneous coronary intervention: Bivalirudin monotherapy or heparin plus a glycoprotein IIb/IIIa inhibitor?
    Krishnamurthy, Pramod
    Donohue, Daniel
    Kothari, Shared
    Krishnan, Prakash
    Kini, Annapoorna S.
    Moreno, Pedro R.
    Sharma, Samin K.
    Kim, Michael C.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A265 - A265
  • [48] Bivalirudin as compared to unfractionated heparin in patients undergoing percutaneous coronary revascularization: A meta-analysis of 22 randomized trials
    Verdoia, Monica
    Schaffer, Alon
    Barbieri, Lucia
    Suryapranata, Harry
    De Luca, Giuseppe
    [J]. THROMBOSIS RESEARCH, 2015, 135 (05) : 902 - 915
  • [49] Efficacy and safety of bivalirudin for percutaneous coronary intervention in acute coronary syndromes: a meta-analysis of randomized-controlled trials
    Nuehrenberg, Thomas G.
    Hochholzer, Willibald
    Mashayekhi, Kambis
    Ferenc, Miroslaw
    Neumann, Franz-Josef
    [J]. CLINICAL RESEARCH IN CARDIOLOGY, 2018, 107 (09) : 807 - 815
  • [50] Efficacy and safety of bivalirudin for percutaneous coronary intervention in acute coronary syndromes: a meta-analysis of randomized-controlled trials
    Thomas G. Nührenberg
    Willibald Hochholzer
    Kambis Mashayekhi
    Miroslaw Ferenc
    Franz-Josef Neumann
    [J]. Clinical Research in Cardiology, 2018, 107 : 807 - 815
12345